MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0007929
Magine Pharmaceuticals Private Limited
Magine Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.4 Cr
▼ 1% YoY
Net profit · FY 2025
₹30,383
Net margin 0.2%
EBITDA · FY 2025
₹1.52 Lakh
EBITDA margin 1.1%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹19 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Magine Pharmaceuticals Private Limited
Data last updated:
Magine Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2011PTC215245. Its GSTIN is 27AAHCM1605P1Z7 (Maharashtra).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹19 Lakh. It was formerly known as Magine Healthcare Private Limited and Mayo Life-Sciences Private Limited. It is led by directors Manu Anil Kagliwal and Usha Anil Kagliwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nath House Nath Road, Aurangabad, Maharashtra, India – 431005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.4 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹30,383 (net margin 0.2%) and EBITDA of ₹1.52 Lakh (EBITDA margin 1.1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over five years.
Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
Magine Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0007929). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2011PTC215245
Registration Number 215245
Incorporation Date 24 March 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0007929
Name history
Magine Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Magine Healthcare Private Limited, Mayo Life-Sciences Private Limited, and Magine Pharmaceuticals Private Limited. The current legal name is Magine Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Magine Pharmaceuticals Private Limited | Current |
| Magine Healthcare Private Limited | Previous |
| Mayo Life-Sciences Private Limited | Previous |
Recognitions & Rankings of Magine Pharmaceuticals
Contact details
Magine Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNath House Nath Road, Aurangabad, Maharashtra, India – 431005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Magine Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Magine Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Magine Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Magine Pharmaceuticals Private Limited, buy the company report.
Financials of Magine Pharmaceuticals Private Limited
FY 2025 filings availableMagine Pharmaceuticals Private Limited reported revenue of ₹1.4 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹1.4 Cr ▼ 1%
Net profit · FY 2025
₹30,383 margin 0.2%
EBITDA · FY 2025
₹1.52 Lakh margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 1%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 2%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 1% fall in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30,383 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Magine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Magine Pharmaceuticals Private Limited
Magine Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Usha Anil Kagliwal | Additional Director | 25 Jul 2014 | 12 Years 3 Months | Current |
| Manu Anil Kagliwal | Director | 24 Mar 2011 | 15 Years 7 Months | Current |
Auditor
Magine Pharmaceuticals Private Limited is audited by SAR&ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAR&ASSOCIATES | FY 2017 | 122400W |
Shareholding
The shareholding of Magine Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Magine Pharmaceuticals Private Limited, buy the company report.
Legal cases
Magine Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Magine Pharmaceuticals. All cases are pending.
Total cases
2
Filed by the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Aurangabad, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Aurangabad, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Magine Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Magine Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM1605P1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Magine Pharmaceuticals Private Limited, buy the company report.
Recent activity
Magine Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Chandrakanta Jayantilal Sancheti ceased to be Additional Director on 14 Mar 2016.
AGM
Magine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Magine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Chandrakanta Jayantilal Sancheti ceased to be Additional Director.
Ceased
Santosh Gulabchand Ladniya ceased to be Director.
Appointed
Usha Anil Kagliwal was appointed as Additional Director.
Appointed
Manu Anil Kagliwal was appointed as Director.
Incorporation
24 Mar 2011
Magine Pharmaceuticals Private Limited was registered on 24 Mar 2011 with Roc Mumbai Ii & aged 15 years 7 months as per MCA records.
Frequently asked questions
Magine Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 March 2011 (15+ years old) and is registered under CIN U74999MH2011PTC215245.
Magine Pharmaceuticals has 2 current directors:
- Usha Anil Kagliwal - Additional Director
- Manu Anil Kagliwal - Director
The latest financial statements of Magine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Magine Pharmaceuticals is 27AAHCM1605P1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Magine Pharmaceuticals is U74999MH2011PTC215245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magine Pharmaceuticals has 2 court cases on record: 2 filed by the company. 2 are pending.
Magine Pharmaceuticals was incorporated on 24 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Chandrakanta Jayantilal Sancheti ceased to be Additional Director on 14 Mar 2016. Santosh Gulabchand Ladniya ceased to be Director on 24 Sep 2014. Usha Anil Kagliwal was appointed as Additional Director on 25 Jul 2014. Magine Pharmaceuticals has 4 board changes on record in total.
Yes, Magine Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0007929).
The registered office of Magine Pharmaceuticals is at Nath House Nath Road, Aurangabad, Maharashtra, India – 431005.